Long Acting B-2 Agonists (LABA) or Anticholinergics (LAMA): Which one is more efficient in Group A COPD Patients?

Access
info:eu-repo/semantics/closedAccessDate
2021Author
Turan, Muzaffer OnurOgan, Nalan
Bozkus, Fulsen
Sarioglu, Nurhan
Turan, Pakize Ayse
Satici, Celal
Metadata
Show full item recordAbstract
[No Abstarct Available]